Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING
April 05, 2024 12:08 ET
|
Hofseth Biocare ASA
Today, 5 April 2024, funds managed by Bonafide (Bonafide Global Fish Fund, Bonafide Best Catches I, HBC I, and HBC II) have purchased approx. 7.1 million shares in Hofseth BioCare ASA (“HBC”),...
Hofseth Biocare ASA: UPDATED COMPANY PRESENTATION
March 21, 2024 05:40 ET
|
Hofseth Biocare ASA
Please find the HBC Company Presentation attached. For further information, please contact: James Berger, Chief Commercial Officer of Hofseth BioCare ASA Phone: +41 79 950 10 34 E-mail:...
Hofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWN
March 14, 2024 07:12 ET
|
Hofseth Biocare ASA
Kristin Fjellby Grung, Chair of the Board of Hofseth BioCare ASA, has informed the Board of Directors that she will resign from the position on 31 March 2024, as she will assume a position as judge in...
Hofseth Biocare ASA: FOURTH QUARTER 2023 AND FULL YEAR FINANCIAL REPORT
February 09, 2024 02:00 ET
|
Hofseth Biocare ASA
HBC had gross operating revenues of NOK 47.4m (33.6m) in the fourth quarter and NOK 218.5m (120.4m) for the full year. Adjusted for the sale of assets in the second quarter, operating revenues were...
Hofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal (anti-androgen) therapy demonstrating significant anti-tumour activity
February 06, 2024 09:56 ET
|
Hofseth Biocare ASA
HBC Immunology Inc. (70.6% owned by Hofseth BioCare ASA) reports today the successful completion of the first in vivo study within its prostate cancer development program. The study assessed whether...
Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED
January 09, 2024 06:44 ET
|
Hofseth Biocare ASA
Reference is made to the stock exchange announcement on 4 January 2024 regarding the conclusion of an extraordinary general meeting in Hofseth Biocare ASA ("HBC" or the "Company") whereby the general...
Hofseth Biocare ASA: EXTRAORDINARY GENERAL MEETING CONCLUDED
January 04, 2024 08:02 ET
|
Hofseth Biocare ASA
Hofseth Biocare ASA ("HBC" or the "Company") has today, on 4 January 2024, completed an extraordinary general meeting. All items proposed on the agenda were adopted, including the share capital...
Hofseth Biocare ASA: EGM Notice Correction
December 15, 2023 05:29 ET
|
Hofseth Biocare ASA
Reference is made to the stock exchange notice announced by Hofseth Biocare ASA ("HBC" or the "Company") on 14 December regarding the notice for an extraordinary general meeting to be held at the...
Hofseth Biocare ASA: Notice of an extraordinary general meeting
December 14, 2023 07:28 ET
|
Hofseth Biocare ASA
Reference is made to the stock exchange notice announced by Hofseth Biocare ASA ("HBC" or the "Company") on 13 December regarding an investment of NOK 144 million from Hofseth International AS...
Hofseth Biocare ASA: SIGNIFICANT NEW INVESTMENT OF NOK 144 MILLION FROM HOFSETH INTERNATIONAL INTO HBC
December 13, 2023 16:49 ET
|
Hofseth Biocare ASA
The board of directors (the “Board”) of Hofseth BioCare ASA ("HBC" or the "Company") has reached an agreement with Hofseth International AS (“Hofseth International”) whereby HBC will issue a new class...